# Cariprazine Effects on Brain and Behavior in Cocaine Use Disorder

> **NCT03430544** · PHASE2 · TERMINATED · sponsor: **Anna Rose Childress, Ph.D.** · enrollment: 14 (actual)

## Conditions studied

- Cocaine Use Disorder

## Interventions

- **DRUG:** Cariprazine Oral Capsule [Vraylar]
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03430544
- **Lead sponsor:** Anna Rose Childress, Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-04
- **Primary completion:** 2020-09-04
- **Final completion:** 2020-09-04
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Low recruitment in final grant year, halted on-site research due to COVID-19 during NCE year.
- **Last updated:** 2020-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430544, "Cariprazine Effects on Brain and Behavior in Cocaine Use Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03430544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*